Gregory S. Hastings, VP of Animal Health at Neogen Corp, filed a Form 4 on October 30, 2026, reporting the vesting and settlement of 1,211 restricted stock units into common stock on October 29, 2026, along with the withholding of 337 shares for tax purposes.

Key Highlights

  • RSU vesting: 1,211 restricted stock units vested and were settled for an equal number of shares of common stock on October 29, 2026.
  • Share withholding: 337 shares were disposed of (transaction code F) at $12.21 per share, reducing the total after the vest.
  • Conversion price: Both the RSU conversion and the share withholding were recorded at $12.21 per share.
  • Resulting ownership: Following both transactions, Hastings directly holds 33,449 shares of common stock.
  • Derivative position cleared: The 1,211 RSUs previously held in Table II now show a balance of 0 following settlement.
  • Filer role: Hastings is identified as an officer with the title VP, Animal Health at Neogen Corp (NASDAQ:NEOG).

RSU Settlement and Share Withholding Details for Hastings at Neogen Corp

According to the filing, Gregory S. Hastings, VP of Animal Health at Neogen Corp (NASDAQ:NEOG), reported two transactions in Table I on October 29, 2026. First, 1,211 shares were acquired (transaction code M) at $12.21, reflecting the conversion of restricted stock units into common stock. Second, 337 shares were disposed of (transaction code F) at $12.21, a transaction type typically associated with shares withheld to cover tax obligations, though the filing does not explicitly state the purpose beyond the code.

The filing's explanation of responses states: "Each RSU is the economic equivalent of one share of common stock. On October 29, 2026, these RSUs vested and were settled for an equal number of shares of common stock." Table II confirms that 1,211 RSUs with a conversion price of $12.21 and an expiration date of October 29, 2026, were settled via transaction code M, leaving a remaining RSU balance of 0. Both the date exercisable and the expiration date for these RSUs are listed as October 29, 2026.

After both reported transactions, Hastings directly beneficially owns 33,449 shares of Neogen Corp common stock, according to the filing. The Form 4 was signed by Christopher Sefcheck as attorney in fact and filed on October 30, 2026. No indirect ownership positions were reported.

What Was Disclosed

The filing reports the October 29, 2026, vesting of 1,211 RSUs into common stock and the same-day withholding of 337 shares at $12.21, resulting in Hastings holding 33,449 shares of Neogen Corp common stock directly.